Dr. Velev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Gove St
East Boston, MA 02128Phone+1 508-650-7000- Is this information wrong?
Summary
- Dr. Nikolai Velev is an internist in East Boston, MA and is affiliated with Boston Medical Center. He received his medical degree from Medical University of Sofia FOM and has been in practice 27 years. He also speaks multiple languages, including Spanish and Bulgarian. He has 4 publications and 20 citings.
Education & Training
- MetroWest Medical CenterResidency, Internal Medicine, 2009 - 2012
- University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia, 2008 - 2009
- University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2006 - 2008
- Medical University of Sofia FOMClass of 1992
Certifications & Licensure
- MA State Medical License 2012 - 2024
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 19 citationsStem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge E. Cortes, Richard E. Champlin, Dan Jones, Gabriela Rondon, Sergio Giralt, Gautam Borthakur, Hagop M. Kantarjian, Marcos de Lima> ;Cancer. 2010 Aug 1
- 1 citationsFailure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cellsJan A. Burger, N S Velev, E. Jabbour, William G. Wierda, Farhad Ravandi, J. E. Cortes, Hagop M. Kantarjian, Yago Nieto, Elizabeth J. Shpall, Jeffrey L. Jorgensen> ;Leukemia. 2010 Jan 1
Journal Articles
- Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR‐ABL kinase domain mutation T315IVelev, N, Cancer, 7/20/2010
- Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cellsBurger,J.. Velev,N, Leukemia, 1/7/2010
Other Languages
- Spanish, Bulgarian
Hospital Affiliations
- Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: